What is SRTS's health score?

Sensus Healthcare, Inc. (SRTS) has a TradeApes health score of 53 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is SRTS's estimated fair value?

Based on our 5-year discounted cash flow model, Sensus Healthcare, Inc.'s estimated fair value is $4.76 per share, representing a 68.7% upside from the current price. This is a model estimate, not a price target or investment recommendation.

Is SRTS undervalued or overvalued?

Our model currently rates SRTS as Undervalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for SRTS... Refresh in a moment for the full analysis.

Sensus Healthcare, Inc. (SRTS)

Healthcare Undervalued low mixed

$2.82

Updated: 2026-06-05

TradeApes Score

Financial Strength

25 Stressed

Operating Trend

58 Mixed

Relative Value

65 Healthy

Capital Allocation

55 Mixed

Risk

80 Strong

Est. Fair Value $4.76

DCF Upside +68.7%

Sector Rank #743 of 6554

Key Findings

+ High FCF yield — above 7%, strong cash return relative to price paid

Unlock Full Report →

− Very high leverage — net debt/EBITDA above 5×

Unlock Full Report →

Create an account for unlimited access

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.